Published in
American Association for the Advancement of Science, Science Translational Medicine, 370(8), 2016
DOI: 10.1126/scitranslmed.aaf2140
Links
- ORCID
- ORCID
- ORCID
- American Association for the Advancement of Science
- ORCID
- ORCID
- ORCID
- [digital.csic.es] | PDF
Tools
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases
Journal article published in 2016 by
Aldo Borroto,
Diana Reyes-Garau,
M. Angeles Jimenez,
Esther Carrasco,
Beatriz Moreno,
S. Martinez-Pasamar,
Sara Martínez-Pasamar,
José R. Cortes,
Almudena Perona,
David Abia,
Soledad Blanco,
Manuel Fuentes 
,
Irene Arellano,
Juan Lobo,
Haleh Heidarieh
and other authors.
,
Irene Arellano,
Juan Lobo,
Haleh Heidarieh
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
A novel inhibitor of interactions between signaling proteins in T cells demonstrates promising preventive and therapeutic effects in several models of autoimmune disease.